Loading organizations...
Loading organizations...
Biopharmaceutical company developing small molecule cancer therapies.
Zentalis Pharmaceuticals has raised $85.0M across 1 funding round.
Zentalis Pharmaceuticals has raised $85.0M in total across 1 funding round.
Zentalis Pharmaceuticals has raised $85.0M in total across 1 funding round.
Zentalis Pharmaceuticals's investors include Eventide Asset Management, Farallon Capital Management, Karan Takhar, Perceptive Advisors, Redmile Group, Surveyor Capital, Viking Global Investors.
Zentalis Pharmaceuticals has raised $85.0M across 1 funding round. Most recently, it raised $85.0M Series C in December 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 9, 2019 | $85.0M Series C | Eventide Asset Management, Farallon Capital Management, Karan Takhar, Perceptive Advisors, Redmile Group, Surveyor Capital, Viking Global Investors |